Education
About Us
Working with TipRanks
Follow Us
Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167)
:1167
RESEARCH TOOLSreports
Total Valuation
Jacobio Pharmaceuticals Group Co., Ltd. has a market cap or net worth of HK$3.53B. The enterprise value is ―.
Market CapHK$3.53B
Enterprise Value―
Share Statistics
Jacobio Pharmaceuticals Group Co., Ltd. has 791,755,070 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding791,755,070
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jacobio Pharmaceuticals Group Co., Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee247.16K
Profits Per Employee-1.40M
Employee Count257
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Jacobio Pharmaceuticals Group Co., Ltd. is ―. Jacobio Pharmaceuticals Group Co., Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Jacobio Pharmaceuticals Group Co., Ltd. had revenue of 63.52M and earned -359.12M in profits. Earnings per share was -0.46.
Revenue63.52M
Gross Profit3.20M
Operating Income-397.88M
Pretax Income-359.12M
Net Income-359.12M
EBITDA-325.73M
Earnings Per Share (EPS)-0.46
Cash Flow
In the last 12 months, operating cash flow was -397.08M and capital expenditures -10.66M, giving a free cash flow of -407.74M billion.
Operating Cash Flow-397.08M
Free Cash Flow-407.74M
Free Cash Flow per Share-0.51
Dividends & Yields
Jacobio Pharmaceuticals Group Co., Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.48
52-Week Price Change139.78%
50-Day Moving Average3.60
200-Day Moving Average2.15
Relative Strength Index (RSI)58.44
Average Volume (3m)5.40M
Important Dates
Jacobio Pharmaceuticals Group Co., Ltd. upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateMar 19, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
Jacobio Pharmaceuticals Group Co., Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Jacobio Pharmaceuticals Group Co., Ltd. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate―
Enterprise Valuation
Jacobio Pharmaceuticals Group Co., Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Jacobio Pharmaceuticals Group Co., Ltd. has HK$1.06B in cash and marketable securities with ¥198.20M in debt, giving a net cash position of -HK$862.00M billion.
Cash & Marketable SecuritiesHK$1.06B
Total Debt¥198.20M
Net Cash-HK$862.00M
Net Cash Per Share-HK$1.09
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Jacobio Pharmaceuticals Group Co., Ltd. is HK$2.05, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$2.05
Price Target Upside-54.04% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast139.04%
EPS Growth Forecast57.13%